InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
0.00%
)
US TECH 100
19,860.40
(
0.07%
)
Dow Jones
39,375.87
(
0.00%
)
Brent Oil
85.93
(
-0.67%
)
Bitcoin
57,396.03
(
2.77%
)
Post# of 252509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 169168

Saturday, 11/02/2013 2:23:09 PM

Saturday, November 02, 2013 2:23:09 PM

Post# of 252509

GILD’s VALENCE study was mentioned at the recent advisory panel, but the data were apparently not yet complete. We can now set aside the mathematical modeling performed by the FDA to extrapolate the SVR rate for >12w treatment in GT3.





Right. The data was close at hand. Apologies go out the FDA likewise.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up